Cisplatin
TERMINATED · PHASE2 · Uterine Cervical Cancer
Problems of recruitment
Registry sourceScientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.
Detailed evidence is available in the local Pro plan simulation.